NASDAQ:CDMO Avid Bioservices (CDMO) Stock Price, News & Analysis $10.23 -0.09 (-0.87%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$10.11▼$10.7850-Day Range$6.70▼$10.3252-Week Range$4.07▼$13.24Volume981,088 shsAverage Volume1.28 million shsMarket Capitalization$650.42 millionP/E RatioN/ADividend YieldN/APrice Target$12.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Avid Bioservices alerts: Email Address Avid Bioservices MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside23.8% Upside$12.67 Price TargetShort InterestBearish19.36% of Shares Sold ShortDividend StrengthN/ASustainability-0.96Upright™ Environmental ScoreNews Sentiment0.44Based on 2 Articles This WeekInsider TradingSelling Shares$197,530 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.64 out of 5 starsMedical Sector490th out of 936 stocksPharmaceutical Preparations Industry226th out of 436 stocks 2.4 Analyst's Opinion Consensus RatingAvid Bioservices has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAvid Bioservices has only been the subject of 1 research reports in the past 90 days.Read more about Avid Bioservices' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted19.36% of the outstanding shares of Avid Bioservices have been sold short.Short Interest Ratio / Days to CoverAvid Bioservices has a short interest ratio ("days to cover") of 11.1, which indicates bearish sentiment.Change versus previous monthShort interest in Avid Bioservices has recently decreased by 0.40%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAvid Bioservices does not currently pay a dividend.Dividend GrowthAvid Bioservices does not have a long track record of dividend growth. Previous Next 4.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAvid Bioservices has received a 68.99% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Biopharmaceuticals", "Clinical research services", and "Process engineering services for the pharmaceutical industry" products. See details.Environmental SustainabilityThe Environmental Impact score for Avid Bioservices is -0.96. Previous Next 1.4 News and Social Media Coverage News SentimentAvid Bioservices has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Avid Bioservices this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for CDMO on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Avid Bioservices to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avid Bioservices insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $197,530.00 in company stock.Percentage Held by InsidersOnly 2.39% of the stock of Avid Bioservices is held by insiders.Percentage Held by Institutions97.16% of the stock of Avid Bioservices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Avid Bioservices' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Avid Bioservices is -4.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avid Bioservices is -4.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvid Bioservices has a P/B Ratio of 3.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Avid Bioservices' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Avid Bioservices Stock (NASDAQ:CDMO)Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.Read More CDMO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CDMO Stock News HeadlinesJuly 12, 2024 | insidertrades.comAvid Bioservices, Inc. (NASDAQ:CDMO) CEO Nicholas Stewart Green Sells 7,657 SharesJuly 26 at 4:00 AM | uk.finance.yahoo.comNasdaq closes on worst day since 2022, Chipotle and IBM earnings: Yahoo FinanceJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 2, 2024 | globenewswire.comAvid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024July 1, 2024 | globenewswire.comAvid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024May 23, 2024 | globenewswire.comAvid Bioservices Earns Committed Badge from EcoVadis for Sustainability PerformanceMay 16, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOMay 7, 2024 | globenewswire.comAvid Bioservices to Participate at Upcoming Investor ConferencesJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 6, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOMay 2, 2024 | finance.yahoo.comSmall Molecule CMO/CDMO Market Outlook 2024-2033: Rising Focus on Personalized Medicine and Niche Therapies WorldwideApril 30, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: AIM ImmunoTech (AIM) and Avid Bioservices (CDMO)April 30, 2024 | finance.yahoo.comQ3 2024 Avid Bioservices Inc Earnings CallApril 24, 2024 | globenewswire.comAvid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024April 21, 2024 | seekingalpha.comLaughing Water Capital - Avid Bioservices: A Few Years Away From Large, Relatively Sticky FCFApril 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOApril 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOMarch 27, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOSee More Headlines Receive CDMO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avid Bioservices and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/02/2024Today7/26/2024Next Earnings (Estimated)9/05/2024Fiscal Year End4/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:CDMO CUSIPN/A CIK704562 Webwww.avidbio.com Phone(714) 508-6100Fax714-838-5817Employees365Year FoundedN/APrice Target and Rating Average Stock Price Target$12.67 High Stock Price Target$16.00 Low Stock Price Target$8.00 Potential Upside/Downside+23.8%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($2.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-140,750,000.00 Net Margins-100.57% Pretax Margin-15.47% Return on Equity-11.27% Return on Assets-4.61% Debt Debt-to-Equity Ratio0.04 Current Ratio0.46 Quick Ratio0.31 Sales & Book Value Annual Sales$139.91 million Price / Sales4.65 Cash Flow$0.17 per share Price / Cash Flow60.88 Book Value$3.02 per share Price / Book3.39Miscellaneous Outstanding Shares63,580,000Free Float62,061,000Market Cap$650.42 million OptionableOptionable Beta1.36 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Nicholas Stewart Green B.Sc. (Age 59)MBA, President, CEO & Director Comp: $1.35MMr. Daniel R. Hart (Age 51)Chief Financial Officer Comp: $719.75kMr. Richard Richieri (Age 59)Chief Operations Officer Comp: $561.68kMr. Mark R. Ziebell J.D. (Age 60)VP, General Counsel & Corporate Secretary Comp: $647.1kMr. Matthew Kwietniak (Age 55)Chief Commercial Officer Comp: $553.59kMs. Oksana LukashVice President of PeopleMore ExecutivesKey CompetitorsUrovant SciencesNASDAQ:UROVG1 TherapeuticsNASDAQ:GTHXRigel PharmaceuticalsNASDAQ:RIGLPandion TherapeuticsNASDAQ:PANDJanux TherapeuticsNASDAQ:JANXView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 19,960 shares on 7/26/2024Ownership: 0.409%Richard A RichieriSold 530 sharesTotal: $4,430.80 ($8.36/share)Matthew R KwietniakSold 119 sharesTotal: $957.95 ($8.05/share)Nicholas Stewart GreenSold 7,657 sharesTotal: $57,733.78 ($7.54/share)Richard A RichieriSold 910 sharesTotal: $6,861.40 ($7.54/share)View All Insider TransactionsView All Institutional Transactions CDMO Stock Analysis - Frequently Asked Questions How have CDMO shares performed this year? Avid Bioservices' stock was trading at $6.50 at the beginning of 2024. Since then, CDMO shares have increased by 57.4% and is now trading at $10.23. View the best growth stocks for 2024 here. How were Avid Bioservices' earnings last quarter? Avid Bioservices, Inc. (NASDAQ:CDMO) announced its quarterly earnings results on Tuesday, July, 2nd. The biopharmaceutical company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.03 by $0.10. The biopharmaceutical company earned $42.98 million during the quarter, compared to analyst estimates of $42.60 million. Avid Bioservices had a negative trailing twelve-month return on equity of 11.27% and a negative net margin of 100.57%. When did Avid Bioservices' stock split? Avid Bioservices's stock reverse split before market open on Monday, July 10th 2017. The 1-7 reverse split was announced on Friday, July 7th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 7th 2017. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. What is Roger Lias' approval rating as Avid Bioservices' CEO? 5 employees have rated Avid Bioservices Chief Executive Officer Roger Lias on Glassdoor.com. Roger Lias has an approval rating of 49% among the company's employees. This puts Roger Lias in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 63.0% of employees surveyed would recommend working at Avid Bioservices to a friend. Who are Avid Bioservices' major shareholders? Top institutional investors of Avid Bioservices include Harbor Capital Advisors Inc. (0.64%) and Bank of New York Mellon Corp (0.41%). Insiders that own company stock include Nicholas Stewart Green, Joseph Carleone, Daniel R Hart, Richard B Hancock, Mark R Ziebell, Richard A Richieri, Matthew R Kwietniak and Gregory Sargen. View institutional ownership trends. How do I buy shares of Avid Bioservices? Shares of CDMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Avid Bioservices own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avid Bioservices investors own include Array Technologies (ARRY), Anavex Life Sciences (AVXL), Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Dynavax Technologies (DVAX), Micron Technology (MU) and QUALCOMM (QCOM). This page (NASDAQ:CDMO) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avid Bioservices, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avid Bioservices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.